Aprea Therapeutics, Inc. Class of Warrant or Right, Outstanding
Aprea Therapeutics, Inc. (APRE) had Class of Warrant or Right, Outstanding of 89.64 million shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-12
- 2026-06-30: Class of Warrant or Right, Outstanding 89.64M shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 90.04M shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 6.89M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2026-06-30 | 89.64M shares 10-Q · filed 2026-08-12 |
| 2026-03-31 | 90.04M shares 10-Q · filed 2026-05-13 |
| 2025-12-31 | 6.89M shares 10-K · filed 2026-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |